Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalTimes Interest Earned

Quantumzyme (QTZM) EBT Margin (2016 - 2018)

Quantumzyme (QTZM) has 4 years of EBT Margin data on record, last reported at 122.63% in Q2 2018.

  • For Q2 2018, EBT Margin fell 15063.0% year-over-year to 122.63%; the TTM value through Oct 2024 reached 293.26%, changed N/A, while the annual FY2018 figure was 30.11%, 6.0% up from the prior year.
  • EBT Margin reached 122.63% in Q2 2018 per QTZM's latest filing, down from 1.32% in the prior quarter.
  • Across five years, EBT Margin topped out at 27.99% in Q2 2017 and bottomed at 122.63% in Q2 2018.
  • Average EBT Margin over 4 years is 24.05%, with a median of 6.0% recorded in 2016.
  • Peak YoY movement for EBT Margin: skyrocketed 8242bps in 2017, then tumbled -15063bps in 2018.
  • A 4-year view of EBT Margin shows it stood at 7.24% in 2015, then crashed by -1150bps to 90.47% in 2016, then skyrocketed by 91bps to 8.05% in 2017, then crashed by -1423bps to 122.63% in 2018.
  • Per Business Quant database, its latest 3 readings for EBT Margin were 122.63% in Q2 2018, 1.32% in Q1 2018, and 8.05% in Q4 2017.